| FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent … W Zhang, M Gordon, AM Schultheis, DY Yang, F Nagashima, M Azuma, ... Journal of Clinical Oncology 25 (24), 3712-3718, 2007 | 483 | 2007 |
| EGFR signaling and drug discovery G Lurje, HJ Lenz Oncology 77 (6), 400-410, 2009 | 463 | 2009 |
| Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models Y Ning, PC Manegold, YK Hong, W Zhang, A Pohl, G Lurje, T Winder, ... International journal of cancer 128 (9), 2038-2049, 2011 | 348 | 2011 |
| A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer RK Ramanathan, CP Belani, DA Singh, M Tanaka, HJ Lenz, Y Yen, ... Cancer chemotherapy and pharmacology 64 (4), 777-783, 2009 | 255 | 2009 |
| Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab AM Schultheis, G Lurje, KE Rhodes, W Zhang, D Yang, AA Garcia, ... Clinical Cancer Research 14 (22), 7554-7563, 2008 | 188 | 2008 |
| Infarct measurement methodology RA Swanson, FR Sharp Journal of Cerebral Blood Flow & Metabolism 14 (4), 697-697, 1994 | 154* | 1994 |
| A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal … W Zhang, T Winder, Y Ning, A Pohl, D Yang, M Kahn, G Lurje, MJ Labonte, ... Annals of Oncology 22 (1), 104-109, 2011 | 152 | 2011 |
| Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent JM Leers, C Vivaldi, H Schäfer, M Bludau, J Brabender, G Lurje, ... Surgical endoscopy 23 (10), 2258-2262, 2009 | 151 | 2009 |
| Gender disparities in metastatic colorectal cancer survival A Hendifar, D Yang, F Lenz, G Lurje, A Pohl, C Lenz, Y Ning, W Zhang, ... Clinical Cancer Research 15 (20), 6391-6397, 2009 | 145 | 2009 |
| Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity D Yang, A Hendifar, C Lenz, K Togawa, F Lenz, G Lurje, A Pohl, T Winder, ... Journal of Gastrointestinal Oncology 2 (2), 77, 2011 | 142 | 2011 |
| Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer G Lurje, W Zhang, AM Schultheis, D Yang, S Groshen, AE Hendifar, ... Annals of Oncology 19 (10), 1734-1741, 2008 | 134 | 2008 |
| Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer … G Lurje, F Nagashima, W Zhang, D Yang, HM Chang, MA Gordon, ... Clinical Cancer Research 14 (23), 7884-7895, 2008 | 120 | 2008 |
| Thymidylate synthase gene variations: predictive and prognostic markers G Lurje, PC Manegold, Y Ning, A Pohl, W Zhang, HJ Lenz Molecular cancer therapeutics 8 (5), 1000-1007, 2009 | 81 | 2009 |
| Monosegment ALPPS hepatectomy: extending resectability by rapid hypertrophy E Schadde, M Malagó, R Hernandez-Alejandro, J Li, E Abdalla, V Ardiles, ... Surgery 157 (4), 676-689, 2015 | 79 | 2015 |
| ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer U Warnecke-Eberz, D Vallböhmer, H Alakus, F Kütting, G Lurje, ... Journal of Gastrointestinal Surgery 13 (8), 1411-1421, 2009 | 75 | 2009 |
| Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer W Zhang, OA Press, CA Haiman, DY Yang, MA Gordon, W Fazzone, ... Journal of Clinical Oncology 25 (24), 3726-3731, 2007 | 71 | 2007 |
| Chemotherapy in advanced nasopharyngeal cancer H Ali, M Al-Sarraf Head & Neck 14 (8), 2000 | 69 | 2000 |
| Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer OA Press, W Zhang, MA Gordon, D Yang, G Lurje, S Iqbal, A El-Khoueiry, ... Cancer research 68 (8), 3037-3042, 2008 | 63 | 2008 |
| Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer G Lurje, W Zhang, D Yang, S Groshen, AE Hendifar, H Husain, ... Pharmacogenetics and genomics 18 (2), 161-168, 2008 | 63 | 2008 |
| Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation MA Gordon, J Gil, B Lu, W Zhang, D Yang, J Yun, S Schneider, S Groshen, ... Future Medicine Ltd 7 (1), 67-88, 2006 | 61 | 2006 |
Peter M. WilsonResearch Associate University of Southern CaliforniaVerified email at qub.ac.uk
